MS Mar 2025 150.000 call
| Previous Close | 0.3700 |
| Open | 0.3700 |
| Bid | 0.0400 |
| Ask | 0.3900 |
| Strike | 150.00 |
| Expire Date | 2025-03-21 |
| Day's Range | 0.3600 - 0.3900 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 30 |
Investor's Business DailyMorgan Stanley Stock Earns IBD Rating Upgrade
A Relative Strength Rating upgrade for Morgan Stanley shows improving technical performance. Will it continue?
The TelegraphMorgan Stanley ditches EU banker bonus cap in boost for London
Morgan Stanley is to scrap the bonus cap for its London bankers in a post-Brexit shake-up that paves the way for multimillion-pound payouts to top performers.
BloombergBicara Therapeutics Picks Morgan Stanley For IPO of Up to $150 Million
(Bloomberg) -- Bicara Therapeutics is working with Morgan Stanley on a US initial public offering, people familiar with the situation said, as the market for first-time share sales is showing signs of normalizing. Most Read from BloombergJustice Department to Charge Boeing, Seeks Guilty Plea from PlanemakerBiden Asks Donors to Stay Following Disastrous DebateBiden's Defiance Has Democrats Fearing They'll Lose White HouseTrump as President or Private Citizen: Why Supreme Court’s Immunity Ruling I
